Genes associated with venous thromboembolism in colorectal cancer patients

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/jth.13926PMID 29247594
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gas6 Promotes Inflammatory (CCR2hiCX3CR1lo) Monocyte Recruitment in Venous Thrombosis

  2017cited by this paper
• RXR Ligands Negatively Regulate Thrombosis and Hemostasis

  2017cited by this paper
• Farnesoid X Receptor and Liver X Receptor Ligands Initiate Formation of Coated Platelets

  2017cited by this paper
• Thrombosis in the setting of cancer.

  2016cited by this paper
• Trousseau's syndrome: cancer-associated thrombosis.

  2016cited by this paper
• REG4 is a transcriptional target of GATA6 and is essential for colorectal tumorigenesis

  2015cited by this paper
• Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer.

  2015cited by this paper
• Venous thromboembolism in cancer patients: an underestimated major health problem

  2015cited by this paper
• Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor?

  2014cited by this paper
• Exposure of Phosphatidylserine by Xk-related Protein Family Members during Apoptosis*

  2014cited by this paper
• Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.

  2013cited by this paper
• Dual Mechanism of Integrin αIIbβ3 Closure in Procoagulant Platelets*

  2013cited by this paper
• Biomarkers for prediction of venous thromboembolism in cancer.

  2013cited by this paper
• Neutrophil extracellular traps

  2013cited by this paper
• Epidemiology of cancer-associated venous thrombosis.

  2013cited by this paper
• Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo

  2012cited by this paper
• Regulation of tissue factor coagulant activity on cell surfaces

  2012cited by this paper
• Paradoxical absence of a prothrombotic phenotype in a mouse model of severe hyperhomocysteinemia.

  2012cited by this paper
• Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation

  2012cited by this paper
• Apelin attenuates hyperoxic lung and heart injury in neonatal rats.

  2010cited by this paper
• Assessing risk of venous thromboembolism in the patient with cancer.

  2009cited by this paper
• Development and validation of a predictive model for chemotherapy-associated thrombosis.

  2008cited by this paper
• Modulation of Tissue Factor–Factor VIIa Signaling by Lipid Rafts and Caveolae

  2007cited by this paper
• Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy

  2007cited by this paper
• Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol.

  2005cited by this paper
• Venous thrombosis: the role of genes, environment, and behavior.

  2005cited by this paper
• Homocysteine and thrombosis: from basic science to clinical evidence

  2005cited by this paper
• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  2002cited by this paper
• Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

  1996cited by this paper
• Ligand-dependent enhancement of human antithrombin gene expression by retinoid X receptor alpha and thyroid hormone receptor beta.

  1996cited by this paper

• Evolving biomarkers and risk prediction models in colorectal cancer-associated venous thromboembolism.

  2026cites this paper
• Genetic markers of thrombophilia as predictors of outcome in colorectal cancer

  2025cites this paper
• Regenerating islet derived Family Member 4 (REG4) does not influence parameters of hemostasis in colorectal cancer.

  2025cites this paper
• The effects of an aggressive breast tumor on thrombosis after antithrombin downregulation in a hypercoagulable mouse model.

  2024cites this paper
• Tumor gene expression is associated with venous thromboembolism in patients with ductal pancreatic adenocarcinoma.

  2024cites this paper
• The association of tumor-expressed REG4, SPINK4 and alpha-1 antitrypsin with cancer-associated thrombosis in colorectal cancer

  2023influential citation
• RNA-sequencing to discover genes and signaling pathways associated with venous thromboembolism in glioblastoma patients: A case-control study.

  2023cites this paper
• Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.

  2022cites this paper
• Assessment of breast cancer progression and metastasis during a hypercoagulable state induced by silencing of antithrombin in a xenograft mouse model.

  2022cites this paper
• Blood coagulation and cancer genes.

  2022cites this paper
• Tumor‐expressed microRNAs associated with venous thromboembolism in colorectal cancer

  2022cites this paper
• Identification of Thrombosis-Related Genes in Patients with Advanced Gastric Cancer: Data from AGAMENON-SEOM Registry

  2022cites this paper
• Neutrophil extracellular traps in gastrointestinal cancer

  2021cites this paper
• Caging the dragon: Research approach to COVID‐19–related thrombosis

  2021cites this paper
• Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles.

  2021cites this paper
• Cancer genes and blood clots.

  2021cites this paper
• Risk Assessment Models for Thrombosis and Anticoagulant-Related Bleeding in Ambulatory Cancer Patients

  2021cites this paper
• Identi cation of critical genes and pathways related to venous thromboembolism in non-small cell lung cancer patients using integrated bioinformatics analysis

  2021cites this paper
• Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?

  2020cites this paper
• Genetic and epigenetic regulation of cancer coagulome - lessons from heterogeneity of cancer cell populations.

  2020cites this paper
• Evaluation of blood gene expression levels in facioscapulohumeral muscular dystrophy patients

  2020cites this paper
• Genes and proteins associated with the risk for cancer-associated thrombosis.

  2020cites this paper
• Effect of thromboprophylaxis on the incidence of venous thromboembolism in surgical patients with colorectal cancer: a meta-analysis.

  2020cites this paper
• Prognostic Factors for Thrombosis in Cancer Patients.

  2019cites this paper
• RNA expression and risk of venous thromboembolism in lung cancer

  2019cites this paper
• Oncogenes and Clotting Factors: The Emerging Role of Tumor Cell Genome and Epigenome in Cancer-Associated Thrombosis

  2019cites this paper
• Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis

  2019cites this paper
• Venous thromboembolism in colorectal surgery: Incidence, risk factors, and prophylaxis.

  2019cites this paper
• Cancer‐associated thrombosis: The search for the holy grail continues

  2018cites this paper
• Unraveling the interplay between cancer and thrombosis: insights from bench to big data

  year unknowncites this paper